Callahan Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Callahan Advisors's LLY Position: Q2 2026 in Review
Callahan Advisors increased its Eli Lilly (LLY) stake by 8.1% in Q2 2026, buying an estimated $1.66M and bringing the position to 21,791 shares worth $26.1M. The position accounts for 1.97% of the portfolio, ranked #15.
Callahan Advisors first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Callahan Advisors held 21,791 shares of Eli Lilly worth $26.1M as of Q2 2026.
- Callahan Advisors bought 1,628 Eli Lilly shares in Q2 2026, an estimated $1.66M.
- Eli Lilly made up 1.97% of Callahan Advisors's portfolio in Q2 2026, its #15 holding.
- Callahan Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Callahan Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.